{"id":"oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","canonicalSlug":"oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","url":"https://wellficent.com/en/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","language":"en","title":"Abu Dhabi white paper outlines four priorities for advanced therapies","summary":"A Future Health–Strategy& report links genomics, clinical trials and regulation; it forecasts cell/gene and RNA/DNA therapy markets could grow seven- to eightfold by 2033.","body":["Future Health – A Global Initiative by Abu Dhabi released a white paper with Strategy& Middle East outlining four priorities for translating next-generation therapeutics into patient care, WAM reported on 22 October. The proposals cover precision clinical trials using genomic and longitudinal health data, managed-access pathways, deeper capabilities in selected therapeutic fields, and tracking long-term patient outcomes.","The paper says genomics, multi-omics and AI can help researchers study disease mechanisms and define patient groups, while increasingly precise therapies may require specialised trials, clinical infrastructure and follow-up evidence. It forecasts that cell and gene therapies and RNA/DNA therapeutics could grow roughly seven- to eightfold from current levels by 2033. The report presents a strategic blueprint and market forecast, not adopted policy or a claim that these therapies are already available through a new Abu Dhabi programme."],"keyPoints":[],"sections":[],"text":"Abu Dhabi white paper outlines four priorities for advanced therapies\n\nA Future Health–Strategy& report links genomics, clinical trials and regulation; it forecasts cell/gene and RNA/DNA therapy markets could grow seven- to eightfold by 2033.\n\nFuture Health – A Global Initiative by Abu Dhabi released a white paper with Strategy& Middle East outlining four priorities for translating next-generation therapeutics into patient care, WAM reported on 22 October. The proposals cover precision clinical trials using genomic and longitudinal health data, managed-access pathways, deeper capabilities in selected therapeutic fields, and tracking long-term patient outcomes.\n\nThe paper says genomics, multi-omics and AI can help researchers study disease mechanisms and define patient groups, while increasingly precise therapies may require specialised trials, clinical infrastructure and follow-up evidence. It forecasts that cell and gene therapies and RNA/DNA therapeutics could grow roughly seven- to eightfold from current levels by 2033. The report presents a strategic blueprint and market forecast, not adopted policy or a claim that these therapies are already available through a new Abu Dhabi programme.","category":"business","region":"world","topics":["ai","non-oil-economy"],"eventDate":"2026-10-22","eventDateBasis":"source-announcement-publication","publishedAt":"2026-10-22T12:10:13Z","modifiedAt":"2026-10-22T12:10:13Z","publicationBasis":"first-publication","preparedAt":"2026-10-22T12:02:44Z","sourcePublishedAt":"2026-10-22","translatedAt":"2026-10-22T12:03:05Z","sources":[{"url":"https://www.wam.ae/en/article/17hjcqb-future-health-sets-out-four-part-abu-dhabi","name":"Emirates News Agency (WAM)","checkedAt":"2026-10-22","attribution":"Future Health sets out four-part Abu Dhabi blueprint for next-generation therapeutics","publishedAt":"2026-10-22"}],"translations":{"en":"https://wellficent.com/en/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","tr":"https://wellficent.com/tr/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","ar":"https://wellficent.com/ar/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","fr":"https://wellficent.com/fr/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","es":"https://wellficent.com/es/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","ru":"https://wellficent.com/ru/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics","pt":"https://wellficent.com/pt/news/oct2026-uae-abu-dhabi-therapeutics-whitepaper-ai-genomics"},"corrections":[],"locations":[],"type":"news","classification":{"version":"1","dataKinds":["project-update","technology-release"],"geographies":[{"role":"issuer-location","countryCode":"AE","subdivisionCode":"AE-AZ"},{"role":"economic-scope","countryCode":"AE","subdivisionCode":"AE-AZ"}],"evidenceBasis":["forecast","plan"],"measurementPeriod":null}}